UBS Group’s Global X Health Care Covered Call & Growth ETF HYLG Stock Holding History

UBS Group’s Portfolio HYLG Stock Details HYLG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-27	Closed	-$708	–	10595
2024 Q3	$708	Buy	+27	New	+$702	﹤0.01%	8843
2024 Q1	–	Sell	-284	Closed	-$6.97K	–	10180
2023 Q4	$6.97K	Buy	+284	New	+$6.89K	﹤0.01%	7655

Other funds holding HYLG

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

UBS Group's HYLG Position: Q4 2024 in Review

UBS Group sold out of Global X Health Care Covered Call & Growth ETF (HYLG) in Q4 2024, closing a stake of 27 shares — an estimated $708 sold.

UBS Group first reported a position in HYLG in Q4 2023 and held it in 2 quarters. The position peaked at $6.97K in Q4 2023. 3 funds tracked by Wall St. Rank hold HYLG as of Q4 2024.

UBS Group reported no remaining Global X Health Care Covered Call & Growth ETF position as of Q4 2024 after selling out during the quarter.
UBS Group sold 27 Global X Health Care Covered Call & Growth ETF shares in Q4 2024, an estimated $708.
UBS Group first reported a position in Global X Health Care Covered Call & Growth ETF in Q4 2023 and held it in 2 quarters.
UBS Group's Global X Health Care Covered Call & Growth ETF position peaked at $6.97K in Q4 2023.
3 funds tracked by Wall St. Rank held Global X Health Care Covered Call & Growth ETF as of Q4 2024.

Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.